Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page is intended to provide access to U.S. Securities and Exchange Commission (SEC) filings for Caring Brands, Inc. (NASDAQ: CABR), a wellness consumer products company focused on over-the-counter (OTC) and cosmetic products. While specific filings are not listed here, company disclosures reference a registration statement on Form S-1 that was filed with the SEC in connection with an underwritten U.S. public offering and uplisting to the Nasdaq Capital Market.
In its public communications, Caring Brands notes that a registration statement on Form S-1 relating to its offering was filed with the SEC and declared effective. It also refers to a final prospectus filed with the SEC in association with that offering. These types of documents typically describe the company’s business, risk factors, capital structure, and use of proceeds, as well as details of the securities being offered.
For a company such as Caring Brands, SEC filings can be a key source of information about its OTC and cosmetic wellness products, its product pipeline, licensing arrangements, and revenue sources from product sales and royalties. They may also discuss intellectual property, clinical validation, and the company’s approach to product development and commercialization.
On Stock Titan, SEC filing pages are designed to surface documents such as registration statements and related materials, and to pair them with AI-powered summaries that explain the main points in accessible language. As new filings become available through the SEC’s EDGAR system, this page can help readers quickly identify the type of document, understand its purpose, and place it in the context of Caring Brands’ broader wellness and capital markets activities.
Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.
Caring Brands, Inc. reported that its Chief Financial Officer, Tyler Moore, resigned from his position effective after notifying the company on January 5, 2026. The company states that his resignation was not due to any disagreement regarding its operations, policies, or practices, which signals this is characterized as an orderly leadership change rather than a dispute.
Caring Brands has begun a search to identify a new Chief Financial Officer and expects to appoint a successor in the near term. Until a replacement is named, the company plans to handle its financial and reporting responsibilities through its existing management team, indicating continuity of core finance functions during the transition.
Caring Brands, Inc. reported that director Hector W. Alila received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of
The options vested immediately on the grant date and are scheduled to expire on
Caring Brands, Inc. reported an insider equity award involving a director who is also a 10% owner. On December 11, 2025, the board, following a recommendation from the compensation committee, approved a grant of 100,000 stock options under the company’s equity incentive plan, with an exercise price of $1.243 per share and no cost to acquire the options themselves.
The options are scheduled to fully vest on June 11, 2026, provided the reporting person continues to serve the company, and they are set to expire on December 11, 2030. After this transaction, the reporting person beneficially owns 100,000 stock options and also holds 2,000,000 shares of Caring Brands common stock.
Caring Brands, Inc. director Christopher Melton reported receiving a stock option grant from the company. On December 11, 2025, the board of directors, following a recommendation from the compensation committee, approved an option for Melton to buy 25,000 shares of common stock at an exercise price of $1.13 per share under the company’s equity incentive plan.
The options vested immediately on December 11, 2025 and expire on December 11, 2030. Following this grant, Melton beneficially owns 25,000 stock options directly.
Caring Brands, Inc. director Christopher Matthew Galeta received a stock option grant on December 11, 2025 under the company’s equity incentive plan. The award covers 25,000 stock options with an exercise price of $1.13 per share, giving him the right to buy 25,000 shares of common stock at that price.
The options were approved by the Board of Directors at the recommendation of the Compensation Committee and vest immediately as of December 11, 2025. After this grant, Galeta beneficially owns 25,000 derivative securities in the form of these stock options, which expire on December 11, 2030.
Caring Brands, Inc. disclosed that its Chief Executive Officer, director, and 10% owner, Dr. Glynn Wilson, received two restricted stock unit (RSU) grants of common stock on December 11, 2025 under the company’s equity incentive plan. The first award covers 126,720 RSUs that fully vest on June 11, 2026, and the second covers 45,872 RSUs that fully vest on December 11, 2026, in each case conditioned on Dr. Wilson’s continued service with the company.
Both grants are shown at a price of $0 per share, reflecting equity compensation rather than an open‑market purchase. Following these awards, Dr. Wilson is reported as beneficially owning 2,172,592 shares of Caring Brands common stock, which includes his prior ownership of 2,000,000 shares.
Caring Brands, Inc. reported that Chief Financial Officer Tyler Thomas Moore received equity awards totaling 300,000 restricted stock units of common stock on December 11, 2025 under its equity incentive plan.
The grants consist of 270,000 restricted stock units that fully vest on June 11, 2026 and 30,000 restricted stock units that fully vest on December 11, 2026, in each case subject to his continued service with the company. Following these awards, he beneficially owns 300,000 shares of common stock directly.